Berna Biotech AG (Swiss Exchange: BBIN) develops, produces and markets vaccines and immunotherapeutics for private and public markets world-wide. Headquartered in Berne, Switzerland, with affiliates in Europe and Korea, Berna is a fully-integrated company with over 900 employees. Berna Biotech's range of novel and validated proprietary technology platforms supports a strong product portfolio. The company markets its core vaccines in the field of hepatitis B, respiratory and travel vaccines and has a broad pipeline of products in development. Development is supported through alliances with academic and commercial partners.